Regs.gov: Substance Abuse and Mental Health Services Administration

SAMHSA Seeks Public Comments on Maternal Mental Health

The Substance Abuse and Mental Health Services Administration (SAMHSA) is soliciting public comments on questions related to maternal mental health. This consultation aims to gather input for the Task Force on Maternal Mental Health.

Proposed Rule to Remove Opioid Disorder Treatment Waiver Requirements

SAMHSA has issued a supplemental notice of proposed rulemaking to remove the waiver requirement for practitioners prescribing certain medications for opioid use disorder (OUD). This action follows amendments made by the Consolidated Appropriations Act, 2023, which eliminated the need for the waiver. Public comments are due by March 14, 2023.

Proposed Rule: Opioid Use Disorder Medication Regulations

The Department of Health and Human Services (HHS) has issued a Notice of Proposed Rulemaking to solicit public comment on proposed modifications to regulations concerning medications for opioid use disorder treatment. The comment period closes on February 14, 2023.

Proposed Federal Workplace Drug Testing Guidelines

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to update federal workplace drug testing guidelines. This consultation seeks public comment on the proposed changes to these guidelines.

SAMHSA Proposed Rule: Mandatory Drug Testing Guidelines Using Oral Fluid

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to establish mandatory guidelines for drug testing using oral fluid. This proposal aims to provide a standardized framework for federal agencies and contractors conducting such testing.